Charles Schwab Investment Management Inc. acquired a new position in shares of Bowhead Specialty Holdings Inc. (NYSE:BOW - Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 65,288 shares of the company's stock, valued at approximately $1,829,000. Charles Schwab Investment Management Inc. owned about 0.20% of Bowhead Specialty at the end of the most recent reporting period.
Other large investors also recently added to or reduced their stakes in the company. Emerald Mutual Fund Advisers Trust boosted its stake in shares of Bowhead Specialty by 0.5% during the 3rd quarter. Emerald Mutual Fund Advisers Trust now owns 194,333 shares of the company's stock worth $5,443,000 after purchasing an additional 937 shares during the period. Point72 Asset Management L.P. bought a new position in shares of Bowhead Specialty during the second quarter valued at approximately $117,000. Sandia Investment Management LP bought a new stake in shares of Bowhead Specialty during the 2nd quarter worth approximately $127,000. Point72 Asia Singapore Pte. Ltd. purchased a new position in Bowhead Specialty during the 2nd quarter valued at $192,000. Finally, Emerald Advisers LLC grew its position in Bowhead Specialty by 3.3% in the 3rd quarter. Emerald Advisers LLC now owns 242,633 shares of the company's stock valued at $6,796,000 after acquiring an additional 7,683 shares during the last quarter.
Wall Street Analyst Weigh In
A number of research firms have recently commented on BOW. JPMorgan Chase & Co. upped their price target on shares of Bowhead Specialty from $26.00 to $30.00 and gave the stock a "neutral" rating in a report on Thursday, November 7th. Keefe, Bruyette & Woods raised their target price on shares of Bowhead Specialty from $35.00 to $36.00 and gave the stock a "market perform" rating in a research report on Wednesday, December 4th. Royal Bank of Canada boosted their price target on Bowhead Specialty from $32.00 to $35.00 and gave the company an "outperform" rating in a report on Wednesday, November 6th. Finally, JMP Securities increased their price objective on Bowhead Specialty from $32.00 to $33.00 and gave the stock a "market outperform" rating in a research note on Wednesday, November 6th. Three equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to data from MarketBeat.com, Bowhead Specialty presently has a consensus rating of "Hold" and a consensus target price of $32.00.
View Our Latest Analysis on BOW
Bowhead Specialty Trading Down 1.8 %
Shares of NYSE:BOW traded down $0.65 during trading hours on Tuesday, hitting $35.65. The company's stock had a trading volume of 100,661 shares, compared to its average volume of 183,112. The firm's fifty day moving average price is $32.88 and its 200 day moving average price is $29.41. Bowhead Specialty Holdings Inc. has a 52 week low of $22.14 and a 52 week high of $37.81.
Bowhead Specialty (NYSE:BOW - Get Free Report) last posted its earnings results on Tuesday, November 5th. The company reported $0.38 earnings per share for the quarter, hitting analysts' consensus estimates of $0.38. The company had revenue of $116.76 million for the quarter, compared to analysts' expectations of $113.00 million. Equities analysts anticipate that Bowhead Specialty Holdings Inc. will post 1.38 EPS for the current fiscal year.
Insider Buying and Selling
In related news, Director Family Mutual Insuran American sold 1,362,285 shares of the stock in a transaction that occurred on Friday, October 25th. The shares were sold at an average price of $27.70, for a total transaction of $37,735,294.50. Following the completion of the sale, the director now owns 4,700,761 shares of the company's stock, valued at $130,211,079.70. This represents a 22.47 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link.
Bowhead Specialty Company Profile
(
Free Report)
Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.
Featured Articles
Before you consider Bowhead Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bowhead Specialty wasn't on the list.
While Bowhead Specialty currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.